Clinical Trial Update: Trial of Theracurmin for Patients With Amyotrophic Lateral Sclerosis (ALS) [Phase 2]

View source ↗

Summary

Phase 2 trial results for Theracurmin in amyotrophic lateral sclerosis have been completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Theracurmin

Snippet

Sponsor: Richard Bedlack, M.D., Ph.D. | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2023-09-28